GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Other Net Income (Loss)

Progen Co (XKRX:296160) Other Net Income (Loss) : ₩ Mil (TTM As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Other Net Income (Loss)?

Progen Co's Other Net Income (Loss) for the six months ended in . 20 was ₩0.00 Mil. Progen Co does not have enough years/quarters to calculate its Other Net Income (Loss) for the trailing twelve months (TTM) ended in . 20.

Progen Co Other Net Income (Loss) Historical Data

The historical data trend for Progen Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Other Net Income (Loss) Chart

Progen Co Annual Data
Trend
Other Net Income (Loss)

Progen Co Semi-Annual Data
Other Net Income (Loss)

Progen Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progen Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Progen Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Progen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Other Net Income (Loss)
Comparable Companies
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Website
http://www.progen.co.kr
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines